
Pentagon Temporarily Rescinds Testosterone Screening Guidance
The story in brief
The Pentagon temporarily rescinded its testosterone screening guidance for US troops on September 2, 2026, to allow updates. The original guidance, set to take effect immediately, aimed to improve military readiness by addressing hormonal and energy-availability issues. Separate screening paths for men and women were outlined during annual health assessments. The FDA plans a mid-September meeting to discuss testosterone's medical use.